Alternative to Warfarin for Arrhythmia Greenville NC

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study. Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity.

Nazim Uddin Azam Khan, MD
PO Box 8168
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Khyber Med Coll, Univ Of Peshawar, Peshawar, Pakistan
Graduation Year: 1985

Data Provided by:
Harry James De Antonio, DO
(252) 816-4176
PCMH 3rd Floor TA #378
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Philadelphia Coll Of Osteo Med, Philadelphia Pa 19131
Graduation Year: 1982

Data Provided by:
Joseph Dolby Babb, MD
(252) 744-4520
3rd Floor Room #378
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1966

Data Provided by:
Assad Movahed, MD
(252) 744-4651
PCMH 3rd Floor TA #378
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Ahwaz Univ, Sch Of Med, (Shahid Chamran Univ) Ahwaz, Iran
Graduation Year: 1975

Data Provided by:
Priya Velappan, MD
Cardiology PCMH-TA Rm 378
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Karen Furlonge Lurito, MD
(252) 816-5601
502 Kensington Dr
Greenville, NC
Specialties
Cardiology
Gender
Female
Education
Medical School: Univ Of Md Sch Of Med, Baltimore Md 21201
Graduation Year: 1996

Data Provided by:
Sanjay Chandrakant Patel, MD
(252) 752-6101
301 Campden Way
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Pecsi Orvostudomanyi Egyetem, Pecs, Hungary
Graduation Year: 1991
Hospital
Hospital: Onslow Memorial Hospital, Jacksonville, Nc
Group Practice: Physicians East Quadrangle Medical Specialists

Data Provided by:
Donald Hugh Tucker, MD
(252) 752-6101
109 Lord Ashley Dr
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Duke Univ Sch Of Med, Durham Nc 27710
Graduation Year: 1958

Data Provided by:
Allen Lewis Oseroff, MD
(252) 728-3000
119 Longmeadow Rd
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: George Washington Univ Sch Of Med & Hlth Sci, Washington Dc 20037
Graduation Year: 1980

Data Provided by:
Michael Kevin Smith, MD
(717) 764-6775
804 Chesapeake Pl
Greenville, NC
Specialties
Cardiology
Gender
Male
Education
Medical School: Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298
Graduation Year: 1998

Data Provided by:
Data Provided by:

Alternative to Warfarin for Arrhythmia

Provided By:

Closing the heart's left atrial appendage could offer an alternative to long-term warfarin treatment for people with non-valvular atrial fibrillation who are at risk for stroke, according to a new study.

Atrial fibrillation, the most common type of irregular heartbeat, causes the upper chambers of the heart to quiver. This can cause blood to pool and form clots in the left atrial appendage (LAA), a long, tubular structure connected to the left atrial cavity. More than 90 percent of atrial blood clots in people with non-valvular atrial fibrillation may originate in the LAA, according to background information in the study.

The study included 463 people who underwent percutaneous implantation of a device, known as the Watchman, to close off the LAA. Their outcomes were compared with those of 244 people who continued long-term treatment with warfarin.

The researchers determined the effectiveness of the treatments by assessing the occurrence, during an average follow-up of 18 months, of strokes, death from cardiovascular causes and systemic embolisms (blood clots that go somewhere other than the brain). They also totaled the occurrence of such serious problems as major bleeding, pericardial effusion (accidental puncture of the heart causing fluid collection in the heart sac) and clots caused by the implanted device.

After 1,065 patient-years of follow-up, there were 3.0 such occurrences per 100 patient-years among those who'd had the device implanted, compared with 4.9 in the warfarin group, for a risk reduction of 38 percent. But people in the device group had more serious safety events -- 7.4 events per 100 patient-years versus 4.4 events in the warfarin group, the researchers found.

"The efficacy of percutaneous closure of the LAA with this device was non-inferior to that of warfarin therapy," concluded Dr. David R. Holmes, of the Mayo Clinic in Rochester, Minn., and his colleagues. "Although there was a higher rate of adverse safety events in the intervention group than the control group, events in the intervention group were mainly a result of periprocedural complications," they wrote.

"Closure of the LAA might provide an alternative strategy to chronic warfarin therapy for stroke prophylaxis in patients with non-valvular atrial fibrillation," they added.

The study appears this week in The Lancet.

More information

The American Academy of Family Physicians has more about atrial fibrillation.

SOURCE: The Lancet, news release, Aug. 13, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com